Department of Social and Behavioral Sciences, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Harvard Medical School, Boston, Massachusetts.
JAMA Intern Med. 2020 Nov 1;180(11):1428-1435. doi: 10.1001/jamainternmed.2020.3552.
Rigorous evidence describing the relationship between private equity acquisition and changes in hospital spending and quality is currently lacking.
To examine changes in hospital income, use, and quality measures that may be associated with private equity acquisition.
DESIGN, SETTING, AND PARTICIPANTS: This cohort study identified 204 hospitals acquired by private equity firms from 2005 to 2017 and 532 matched hospitals not acquired by private equity. Using a difference-in-differences design, this study evaluated changes in net income, charges, charge to cost ratios, case mix index (a measure of reported illness burden), share of discharges for patients with Medicare or Medicaid coverage, discharges per year, and aggregate hospital quality measures associated with private equity acquisition through 3 years after acquisition, adjusted for case mix, hospital beds, calendar year, and adjustment for multiple hypothesis testing. In subgroup analyses, changes in outcomes for private equity-owned Hospital Corporation of America (HCA) hospitals and non-HCA hospitals relative to matched controls were assessed.
Eight hospital income and use measures and 3 aggregate hospital quality measures were examined.
Relative to 532 control hospitals, the 204 private equity-acquired hospitals showed a mean increase of $2 302 391 (95% CI, $956 660-$3 648 123; P = .009) in annual net income, an increase of $407 (95% CI, $296-$518; P < .001) in total charge per inpatient day, an increase of 0.61 (95% CI, 0.48-0.73; P < .001) in emergency department charge to cost ratio, an increase of 0.31 (95% CI, 0.26-0.37; P < .001) in total charge to cost ratio, an increase of 0.02 (95% CI, 0.01-0.02; P = .007) in case mix index, and a decrease of 0.96% (95% CI, 0.46%-1.45%; P = .002) in share of Medicare discharges. Medicaid's share of discharges (-0.16%; 95% CI, -0.86% to 0.53%; P > .99) and total hospital discharges (98; 95% CI, -54 to 250; P > .99) did not change differentially in a statistically significant manner. The aggregate quality score for acute myocardial infarction increased by 3.3% (95% CI, 1.6%-5.0%; P = .002), and the aggregate score for pneumonia increased by 2.9% (95% CI, 1.8%-3.9%; P < .001) in private equity-acquired hospitals relative to controls. The aggregate score for heart failure (1.3%; 95% CI, -0.2% to 2.7%; P = .92) did not differentially change in a statistically significant manner. In subgroup analyses, HCA hospitals showed similar findings to the entire sample. Among non-HCA hospitals, the only statistically significant relative changes were the increase in the emergency department charge to cost ratio (0.30; 95% CI, 0.12-0.48; P = .02) and the decrease in Medicare's share (-1.15%; 95% CI, -1.88% to -0.43%; P = .02). Non-HCA hospitals showed a decrease in the aggregate heart failure score (-3.3%; 95% CI, -5.3% to -1.3%; P = .01) and no statistically significant changes in the aggregate score for acute myocardial infarction (2.4%; 95% CI, -0.7% to 5.4%; P > .99) or pneumonia (0.2%; 95% CI, -1.4% to 1.7%; P > .99).
Hospitals acquired by private equity were associated with larger increases in net income, charges, charge to cost ratios, and case mix index as well as with improvement in some quality measures after acquisition relative to nonacquired controls. Heterogeneity in some findings was observed between HCA and non-HCA hospitals.
重要性:目前缺乏严格的证据描述私募股权收购与医院支出和质量变化之间的关系。
目的:研究可能与私募股权收购相关的医院收入、使用和质量指标的变化。
设计、设置和参与者:本队列研究确定了 204 家 2005 年至 2017 年期间被私募股权公司收购的医院和 532 家未被私募股权收购的匹配医院。采用差异法设计,通过 3 年的调整,评估了与收购相关的净收入、收费、收费成本比、病例组合指数(报告疾病负担的衡量标准)、医疗保险或医疗补助覆盖的出院人数、每年出院人数以及与医院质量相关的 3 个综合指标的变化,考虑了病例组合、医院床位、日历年和多重假设检验的调整。在亚组分析中,评估了私募股权拥有的 HCA 医院和非 HCA 医院与匹配对照组相比的结果变化。
主要结果和措施:检查了 8 项医院收入和使用指标以及 3 项综合医院质量指标。
结果:与 532 家对照医院相比,204 家被私募股权收购的医院的年净收入平均增加了 2302391 美元(95%CI,956660-3648123;P=0.009),每位住院患者的总收费增加了 407 美元(95%CI,296-518;P<0.001),急诊收费成本比增加了 0.61(95%CI,0.48-0.73;P<0.001),总收费成本比增加了 0.31(95%CI,0.26-0.37;P<0.001),病例组合指数增加了 0.02(95%CI,0.01-0.02;P=0.007),医疗保险出院人数下降了 0.96%(95%CI,0.46%-1.45%;P=0.002)。医疗保险出院人数(-0.16%;95%CI,-0.86%至 0.53%;P>0.99)和总出院人数(98;95%CI,-54 至 250;P>0.99)没有发生有统计学意义的差异变化。急性心肌梗死的综合质量评分增加了 3.3%(95%CI,1.6%-5.0%;P=0.002),肺炎的综合评分增加了 2.9%(95%CI,1.8%-3.9%;P<0.001),与对照组相比。心力衰竭的综合评分(1.3%;95%CI,-0.2%至 2.7%;P=0.92)没有发生有统计学意义的差异变化。在亚组分析中,HCA 医院的发现与整个样本相似。在非 HCA 医院中,唯一具有统计学意义的相对变化是急诊收费成本比增加了 0.30(95%CI,0.12-0.48;P=0.02),医疗保险份额减少了 1.15%(95%CI,-1.88%至-0.43%;P=0.02)。非 HCA 医院的心力衰竭综合评分下降了 3.3%(95%CI,-5.3%至-1.3%;P=0.01),急性心肌梗死的综合评分没有统计学意义的变化(2.4%;95%CI,-0.7%至 5.4%;P>0.99)或肺炎(0.2%;95%CI,-1.4%至 1.7%;P>0.99)。
结论和相关性:与非收购控制组相比,被私募股权收购的医院在净收入、收费、收费成本比和病例组合指数方面的增长更大,并且在收购后一些质量指标有所改善。在 HCA 和非 HCA 医院之间观察到一些发现存在异质性。